Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GLIOBLASTOMA MULTIFORME”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07779798
What this trial is testing

A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-663 in Participants With Relapsed or Refractory Myeloid Malignancies, Advanced Solid Tumors, or Recurrent or Progressive Glioblastoma.

Who this might be right for
Advanced Solid TumorsRecurrent or Progressive GlioblastomaRelapse or Refractory Myeloid Malignancies
Crossbow Therapeutics, Inc. 120
Testing effectiveness (Phase 2)UnknownNCT05033587
What this trial is testing

Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.

Who this might be right for
MGMT-Unmethylated Glioblastoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 28
Early research (Phase 1)Study completedNCT00770471
What this trial is testing

ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24
Testing effectiveness (Phase 2)Study completedNCT00575887
What this trial is testing

Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma

Who this might be right for
GlioblastomaAstrocytomaOligodendroglioma+1 more
Marmara University 25
Not applicableUnknownNCT03160599
What this trial is testing

Restricted Calorie Ketogenic Diet as a Treatment in Malignant Tumors

Who this might be right for
Malignant Tumors
Second Affiliated Hospital of Guangzhou Medical University 40
Testing effectiveness (Phase 2)Study completedNCT00795665
What this trial is testing

Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma

Who this might be right for
Glioma
University of California, Davis 7
Large-scale testing (Phase 3)Study completedNCT03776071
What this trial is testing

A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1

Who this might be right for
Glioblastoma
Denovo Biopharma LLC 260
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Not applicableUnknownNCT05728125
What this trial is testing

Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients

Who this might be right for
Glioblastoma
Power Life Sciences Inc. 500
Testing effectiveness (Phase 2)Study completedNCT00045708
What this trial is testing

A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Giant Cell GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 57
Testing effectiveness (Phase 2)Ended earlyNCT03022578
What this trial is testing

Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

Who this might be right for
IDH Family WildtypeRecurrent Anaplastic AstrocytomaRecurrent Glioblastoma
M.D. Anderson Cancer Center 7
Large-scale testing (Phase 3)UnknownNCT03633552
What this trial is testing

Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma

Who this might be right for
Glioblastoma Multiforme of BrainAnaplastic Astrocytoma of Brain
Mashhad University of Medical Sciences 62
Testing effectiveness (Phase 2)Study completedNCT03797326
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

Who this might be right for
Advanced Solid TumorsTriple Negative Breast CancerOvarian Cancer+5 more
Merck Sharp & Dohme LLC 611
Testing effectiveness (Phase 2)Looking for participantsNCT07263438
What this trial is testing

Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial

Who this might be right for
GlioblastomaRecurrence Tumor
Centre Hospitalier Universitaire Vaudois 59
Early research (Phase 1)Study completedNCT00025558
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer

Who this might be right for
Brain and Central Nervous System Tumors
NYU Langone Health
Testing effectiveness (Phase 2)Study completedNCT03744026
What this trial is testing

Safety and Efficacy of Transient Opening of the Blood-brain Barrier (BBB) With the SonoCloud-9

Who this might be right for
Glioblastoma, Adult
CarThera 38
Early research (Phase 1)Study completedNCT02502708
What this trial is testing

Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors

Who this might be right for
Glioblastoma MultiformeGliomaGliosarcoma+5 more
NewLink Genetics Corporation 81
Post-approval studies (Phase 4)WithdrawnNCT05900908
What this trial is testing

Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy

Who this might be right for
Glioblastoma
GT Medical Technologies, Inc.
Testing effectiveness (Phase 2)Study completedNCT02794883
What this trial is testing

Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaRecurrent Glioblastoma
Northwestern University 36
Not applicableStudy completedNCT03390569
What this trial is testing

Exercise in Patients With Glioblastoma

Who this might be right for
Glioblastoma
University Health Network, Toronto 54
Next Page